Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data - Global Forecast to 2026

世界の肺がん手術市場予測:器具別、処置別、ボリュームデータ別

◆タイトル:Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data - Global Forecast to 2026
◆商品コード:MD4960
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年6月20日
◆ページ数:165
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は世界の肺がん手術市場規模が2020年54億ドルから2026年67億ドルまで、年平均3.8%成長すると予想しています。本市場調査レポートでは、肺がん手術の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、機器種類別(手術器具、監視・視覚化システム、内科機器)分析、方法種類別(開胸術、低侵襲手術)分析、地域別分析、競争状況、企業情報など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の肺がん手術市場規模:機器種類別(手術器具、監視・視覚化システム、内科機器)
・世界の肺がん手術市場規模:方法種類別(開胸術、低侵襲手術)
・世界の肺がん手術市場規模:地域別
・競争状況
・企業情報

“The global lung cancer surgery market is projected to reach USD 6.7 billion by 2026 from USD 5.4 billion in 2020, at a CAGR of 3.8% during the forecast period.”
Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, growing trend of smoking tobacco, rising geriatric population, increasing emphasis on early diagnosis & treatment of cancers, and availability of reimbursement.

“The surgical instruments segment accounted for the highest growth rate in the lung cancer surgery market, by surgical devices, during the forecast period.”
Based on devices, the lung cancer surgery market is segmented into surgical instruments, monitoring & visualizing, and endosurgical equipment. In 2020, the surgical instruments segment accounted for the largest market share. The rising prevalence & incidence of lung cancer, rising government support and funding, and the increasing adoption of surgical procedures for lung cancer treatment are the factors driving the market growth.

“Minimally Invasive Surgeries segment accounted for the highest CAGR.”
Based on procedures, the lung cancer surgery market is segmented into thoracotomy and minimally invasive surgeries. In 2020, the thoracotomy segment accounted for the larger share of the lung cancer surgery market. However, the minimally invasive surgeries segment is expected to grow at the highest CAGR. The growing adoption of minimally invasive techniques, increasing technological advancements, availability of reimbursement policies, and the increasing trend of robotic surgeries are the factors driving the growth of this market segment.

“Asia Pacific: The fastest-growing region lung cancer surgery market.”
The Asian market is expected to witness the highest growth during the forecast period, primarily due to the increasing incidence and prevalence of lung cancer, and rising trend of smoking tobacco.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 55%, Europe – 25%, Asia – 15, and RoW – 5%

List of companies profiled in the report:
• Accuray Inc. (US)
• AngioDynamics Inc. (US)
• Ethicon US, LLC (US)
• Intuitive Surgical Inc. (US)
• Olympus Corporation (Japan)
• Teleflex Incorporated (US)
• Ackermann Instrumente GmbH (Germany)
• KARL STORZ GmbH (Germany)
• Scanlan International Inc. (US)
• TROKAMED GmbH (Germany)
• Medtronic Plc. (Ireland)
• Siemens Healthcare (Germany)
• Richard Wolf GmbH (Germany)
• Phoenix Surgical Holdings Limited (England)
• Key Surgical LLC (US)
• Surgical Holdings (England)
• FusionKraft (India)
• KLS Martin Group (Germany)
• Sontec Instruments Inc. (US)
• Wexler Surgical Inc. (US)

Research Coverage:
This report provides a detailed picture of the global lung cancer surgery market. It aims at estimating the size and future growth potential of the market across different segments, such as devices, procedures, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall lung cancer surgery market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

【レポートの目次】

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21
1.7 SUMMARY OF CHANGES 21
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
FIGURE 1 RESEARCH DESIGN 23
2.1.1 SECONDARY DATA 24
2.1.1.1 Secondary sources 24
2.2 PRIMARY DATA 25
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 25
2.3 MARKET SIZE ESTIMATION 26
2.3.1 BOTTOM-UP APPROACH 26
FIGURE 3 LUNG CANCER SURGERY MARKET: BOTTOM-UP APPROACH 26
2.3.2 TOP-DOWN APPROACH 27
FIGURE 4 LUNG CANCER SURGERY MARKET: TOP-DOWN APPROACH 27
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 27
FIGURE 5 DATA TRIANGULATION METHODOLOGY 28
2.5 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
FIGURE 6 LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020 VS. 2026 (USD MILLION) 30
FIGURE 7 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020 VS. 2026 (USD MILLION) 31
FIGURE 8 LUNG CANCER SURGICAL INSTRUMENTS MARKET, BY TYPE,
2020 VS. 2026 (USD MILLION) 32
FIGURE 9 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION,
2020 VS. 2026 (USD MILLION) 32

4 PREMIUM INSIGHTS 34
4.1 LUNG CANCER SURGICAL DEVICES MARKET OVERVIEW 34
FIGURE 10 RISING INCIDENCE OF LUNG CANCER TO DRIVE OVERALL MARKET GROWTH DURING THE FORECAST PERIOD 34
4.2 HAND INSTRUMENT MARKET, BY TYPE, 2020 VS. 2026 (USD MILLION) 35
FIGURE 11 STAPLER SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE MARKET IN 2020 35
4.3 MONITORING & VISUALIZING SYSTEMS MARKET, BY TYPE,
2020 VS. 2026 (USD MILLION) 36
FIGURE 12 THE CAMERAS AND VIDEO SUPPORT SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 (USD MILLION) 36
4.4 LUNG CANCER SURGERY DEVICES MARKET, BY REGION, (2020−2026) 36
FIGURE 13 ASIA TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
FIGURE 14 LUNG CANCER SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 37
5.2.1 DRIVERS 38
5.2.1.1 Increasing incidence of lung cancer 38
5.2.1.1.1 The growing trend of smoking tobacco 38
5.2.1.1.2 Rising geriatric population 39
5.2.1.2 Increasing emphasis on early diagnosis & treatment of cancers 39
5.2.1.2.1 Increasing funding for early detection of cancer 39
5.2.1.2.2 Rising number of diagnostic centers for the early detection of cancer 40
5.2.1.3 Rising technological advancements in lung cancer treatment 40
5.2.1.4 Availability of reimbursements 40
5.2.2 RESTRAINTS 41
5.2.2.1 The high cost of lung cancer diagnosis & treatments 41
5.2.3 OPPORTUNITIES 42
5.2.3.1 Emerging economies 42
5.2.4 CHALLENGES 42
5.2.4.1 Increasing adoption of refurbished imaging systems 42
5.2.4.2 The dearth of skilled oncologists 42
5.3 COVID – 19 IMPACT ANALYSIS IN THE LUNG CANCER SURGERY MARKET 43

6 LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE 44
6.1 INTRODUCTION 45
TABLE 1 LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 45
TABLE 2 LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 45
6.2 SURGICAL INSTRUMENTS 46
TABLE 3 SURGICAL INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 46
TABLE 4 SURGICAL INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 46
TABLE 5 SURGICAL INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 46
TABLE 6 SURGICAL INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 47
6.2.1 POWERED SURGICAL INSTRUMENTS 47
6.2.1.1 Consistent performance and optimum functionality during surgical procedures to drive the market growth for powered instruments 47
TABLE 7 POWERED SURGICAL INSTRUMENTS MARKET, BY REGION,
2016–2019 (USD MILLION) 47
TABLE 8 POWERED SURGICAL INSTRUMENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 48
6.2.2 HAND INSTRUMENTS 48
TABLE 9 HAND INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 48
TABLE 10 HAND INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 49
TABLE 11 HAND INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 49
TABLE 12 HAND INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 49
6.2.2.1 Staplers 50
6.2.2.1.1 Time effectivity of staplers over suturing to drive the market growth 50
TABLE 13 HAND INSTRUMENTS MARKET FOR STAPLERS, BY REGION, 2016–2019 (USD MILLION) 50
TABLE 14 HAND INSTRUMENTS MARKET FOR STAPLERS, BY REGION,
2020–2026 (USD MILLION) 50
6.2.2.2 Forceps 51
6.2.2.2.1 Surgical forceps are the most widely used instruments 51
TABLE 15 HAND INSTRUMENTS MARKET FOR FORCEPS, BY REGION,
2016–2019 (USD MILLION) 51
TABLE 16 HAND INSTRUMENTS MARKET FOR FORCEPS, BY REGION,
2020–2026 (USD MILLION) 51
6.2.2.3 Retractors 52
6.2.2.3.1 Retractors are flexible; key factor driving market growth 52
TABLE 17 HAND INSTRUMENTS MARKET FOR RETRACTORS, BY REGION,
2016–2019 (USD MILLION) 52
TABLE 18 HAND INSTRUMENTS MARKET FOR RETRACTORS, BY REGION,
2020–2026 (USD MILLION) 52

6.2.2.4 Rib Shears 53
6.2.2.4.1 Increasing thoracotomy procedures worldwide to drive the adoption of rib shears 53
TABLE 19 HAND INSTRUMENTS MARKET FOR RIB SHEARS, BY REGION,
2016–2019 (USD MILLION) 53
TABLE 20 HAND INSTRUMENTS MARKET FOR RIB SHEARS, BY REGION,
2020–2026 (USD MILLION) 53
6.2.2.5 Cutters 54
6.2.2.5.1 Use of mechanical cutters for debridement procedures to drive the market growth 54
TABLE 21 HAND INSTRUMENTS MARKET FOR CUTTERS, BY REGION,
2016–2019 (USD MILLION) 54
TABLE 22 HAND INSTRUMENTS MARKET FOR CUTTERS, BY REGION,
2020–2026 (USD MILLION) 54
6.2.2.6 Clamps 55
6.2.2.6.1 Clamps are lightweight; key factor driving market growth 55
TABLE 23 HAND INSTRUMENTS MARKET FOR CLAMPS, BY REGION,
2016–2019 (USD MILLION) 55
TABLE 24 HAND INSTRUMENTS MARKET FOR CLAMPS, BY REGION,
2020–2026 (USD MILLION) 55
6.2.2.7 Scissors 56
6.2.2.7.1 Scissors are an essential tool in surgeries as they have versatile applications 56
TABLE 25 HAND INSTRUMENTS MARKET FOR SCISSORS, BY REGION,
2016–2019 (USD MILLION) 56
TABLE 26 HAND INSTRUMENTS MARKET FOR SCISSORS, BY REGION,
2020–2026 (USD MILLION) 56
6.2.2.8 Trocars 57
6.2.2.8.1 The increasing number of cardiothoracic surgeries to drive the market growth for trocars 57
TABLE 27 HAND INSTRUMENTS MARKET FOR TROCARS, BY REGION,
2016–2019 (USD MILLION) 57
TABLE 28 HAND INSTRUMENTS MARKET FOR TROCARS, BY REGION,
2020–2026 (USD MILLION) 57
6.2.2.9 Elevators 58
6.2.2.9.1 Elevators help in the clear visualization of a body cavity 58
TABLE 29 HAND INSTRUMENTS MARKET FOR ELEVATORS, BY REGION,
2016–2019 (USD MILLION) 58
TABLE 30 HAND INSTRUMENTS MARKET FOR ELEVATORS, BY REGION,
2020–2026 (USD MILLION) 58
6.2.2.10 Other Hand Instruments 58
TABLE 31 OTHER HAND INSTRUMENTS MARKET, BY REGION,
2016–2019 (USD MILLION) 59
TABLE 32 OTHER HAND INSTRUMENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 59

6.3 MONITORING AND VISUALIZING SYSTEMS 59
TABLE 33 MONITORING AND VISUALIZING SYSTEMS MARKET, BY TYPE,
2016–2019 (USD MILLION) 60
TABLE 34 MONITORING AND VISUALIZING SYSTEMS MARKET, BY TYPE,
2020–2026 (USD MILLION) 60
TABLE 35 MONITORING AND VISUALIZING SYSTEMS MARKET, BY REGION,
2016–2019 (USD MILLION) 60
TABLE 36 MONITORING AND VISUALIZING SYSTEMS MARKET, BY REGION,
2020–2026 (USD MILLION) 60
6.3.1 CAMERAS AND VIDEO SUPPORT 61
6.3.1.1 Improved quality of images and visualization during surgeries to drive the market growth of this segment 61
TABLE 37 MONITORING AND VISUALIZING SYSTEMS MARKET FOR CAMERAS AND VIDEO SUPPORT, BY REGION, 2016–2019 (USD MILLION) 61
TABLE 38 MONITORING AND VISUALIZING SYSTEMS MARKET FOR CAMERAS AND VIDEO SUPPORT, BY REGION, 2020–2026 (USD MILLION) 61
6.3.2 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS 62
6.3.2.1 Increasing endoscopic surgeries for lung cancer to drive the market growth of this segment 62
TABLE 39 MONITORING AND VISUALIZING SYSTEMS MARKET FOR ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2016–2019 (USD MILLION) 62
TABLE 40 MONITORING AND VISUALIZING SYSTEMS MARKET FOR ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2020–2026 (USD MILLION) 62
6.4 ENDOSURGICAL EQUIPMENT 63
6.4.1 INCREASING ADOPTION OF ROBOTIC SURGERIES FOR LUNG CANCER TO DRIVE THE MARKET GROWTH 63
TABLE 41 ENDOSURGICAL EQUIPMENT MARKET, BY REGION, 2016–2019 (USD MILLION) 63
TABLE 42 ENDOSURGICAL EQUIPMENT MARKET, BY REGION, 2020–2026 (USD MILLION) 63
7 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE 64
7.1 INTRODUCTION 65
TABLE 43 LUNG CANCER SURVIVAL RATE FOR DIFFERENT STAGES, BY TYPE OF LUNG CANCER, 2021 65
TABLE 44 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 65
TABLE 45 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 66
TABLE 46 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 66
TABLE 47 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 66
7.2 THORACOTOMY 67
TABLE 48 LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY,
BY TYPE, 2016–2019 (NO. OF PROCEDURES) 67
TABLE 49 LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY,
BY TYPE, 2020–2026 (NO. OF PROCEDURES) 67
TABLE 50 LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY,
BY REGION, 2016–2019 (USD MILLION) 68
TABLE 51 LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY,
BY REGION, 2020–2026 (USD MILLION) 68
TABLE 52 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE THORACOTOMY,
BY REGION, 2016–2019 (NO. OF PROCEDURES) 68
TABLE 53 LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY,
BY REGION, 2020–2026 (NO. OF PROCEDURES) 69
7.2.1 LOBECTOMY 69
7.2.1.1 The probability of getting rid of the primary source of cancer with this technique is a major factor driving the market growth 69
TABLE 54 LUNG CANCER SURGICAL PROCEDURES MARKET FOR LOBECTOMY,
BY REGION, 2016–2019 (NO. OF PROCEDURES) 69
TABLE 55 LUNG CANCER SURGICAL PROCEDURES MARKET FOR LOBECTOMY,
BY REGION, 2020–2026 (NO. OF PROCEDURES) 70
7.2.2 SLEEVE RESECTION 70
7.2.2.1 Sleeve resection enables the removal of centrally located tumors 70
TABLE 56 LUNG CANCER SURGICAL PROCEDURES MARKET FOR SLEEVE RESECTION, BY REGION, 2016–2019 (NO. OF PROCEDURES) 70
TABLE 57 LUNG CANCER SURGICAL PROCEDURES MARKET FOR SLEEVE RESECTION, BY REGION, 2020–2026 (NO. OF PROCEDURES) 71
7.2.3 SEGMENTECTOMY 71
7.2.3.1 Segmentectomy is performed to remove the portion of a lobe during early-stage cancer 71
TABLE 58 LUNG CANCER SURGICAL PROCEDURES MARKET FOR SEGMENTECTOMY,
BY REGION, 2016–2019 (NO. OF PROCEDURES) 71
TABLE 59 LUNG CANCER SURGICAL PROCEDURES MARKET FOR SEGMENTECTOMY,
BY REGION, 2020–2026 (NO. OF PROCEDURES) 72
7.2.4 PNEUMONECTOMY 72
7.2.4.1 Pneumonectomy is an open surgery performed to treat lung cancer 72
TABLE 60 LUNG CANCER SURGICAL PROCEDURES MARKET FOR PNEUMONECTOMY,
BY REGION, 2016–2019 (NO. OF PROCEDURES) 72
TABLE 61 LUNG CANCER SURGICAL PROCEDURES MARKET FOR PNEUMONECTOMY,
BY REGION, 2020–2026 (NO. OF PROCEDURES) 73
7.3 MINIMALLY INVASIVE SURGERIES 73
7.3.1 SHORTER HOSPITAL STAYS, QUICKER RECOVERY, AND SMALLER INCISIONS ARE FACTORS DRIVING THE GROWTH OF MIS 73
TABLE 62 LUNG CANCER SURGICAL PROCEDURES MARKET FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2016–2019 (USD MILLION) 74
TABLE 63 LUNG CANCER SURGICAL PROCEDURES MARKET FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2020–2026 (USD MILLION) 74
TABLE 64 LUNG CANCER SURGICAL PROCEDURES MARKET FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2016–2019 (NO. OF PROCEDURES) 74
TABLE 65 LUNG CANCER SURGICAL PROCEDURES MARKET FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2020–2026 (NO. OF PROCEDURES) 75

8 LUNG CANCER SURGERY MARKET, BY REGION 76
8.1 INTRODUCTION 77
TABLE 66 LUNG CANCER SURGICAL DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 77
TABLE 67 LUNG CANCER SURGICAL DEVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 77
TABLE 68 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION,
2016–2019 (USD MILLION) 78
TABLE 69 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION,
2020–2026 (USD MILLION) 78
TABLE 70 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION,
2016–2019 (NO. OF PROCEDURES) 78
TABLE 71 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION,
2020 – 2026 (NO. OF PROCEDURES) 79
8.2 NORTH AMERICA 79
8.2.1 RISING GROWTH INITIATIVES UNDERTAKEN BY KEY PLAYERS TO DRIVE MARKET GROWTH 79
TABLE 72 LIST OF RELATED CONFERENCES IN NORTH AMERICA, 2021 80
FIGURE 15 NORTH AMERICA: LUNG CANCER SURGERY MARKET SNAPSHOT 80
TABLE 73 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 81
TABLE 74 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 81
TABLE 75 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY, 2016–2019 (NO. OF PROCEDURES) 81
TABLE 76 NORTH AMERICA: LUNG CANCER SURGERY MARKET, BY COUNTRY,
2020–2026 (NO. OF PROCEDURES) 81
TABLE 77 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 82
TABLE 78 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 82
TABLE 79 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (USD MILLION) 82
TABLE 80 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (USD MILLION) 82
TABLE 81 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 83
TABLE 82 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 83
TABLE 83 NORTH AMERICA: THORACOTOMY MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 83
TABLE 84 NORTH AMERICA: THORACOTOMY MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 83

8.2.2 US 84
8.2.2.1 Rising healthcare spending to drive the market growth in the US 84
TABLE 85 US: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 84
TABLE 86 US: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 84
TABLE 87 US: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 85
TABLE 88 US: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 85
TABLE 89 US: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 85
TABLE 90 US: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 85
TABLE 91 US: THORACOTOMY MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 86
TABLE 92 US: THORACOTOMY MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 86
8.2.3 CANADA 86
8.2.3.1 Increasing incidences of lung cancer to drive the market growth in Canada 86
TABLE 93 CANADA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 87
TABLE 94 CANADA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 87
TABLE 95 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 87
TABLE 96 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 87
TABLE 97 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 88
TABLE 98 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 88
TABLE 99 CANADA: THORACOTOMY MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 88
TABLE 100 CANADA: THORACOTOMY MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 88
8.3 EUROPE 89
TABLE 101 EUROPE: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 89
TABLE 102 EUROPE: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 90
TABLE 103 EUROPE: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 90
TABLE 104 EUROPE: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 90
TABLE 105 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 91
TABLE 106 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 91
TABLE 107 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 91
TABLE 108 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 91
TABLE 109 EUROPE: THORACOTOMY MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 92
TABLE 110 EUROPE: THORACOTOMY MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 92
8.3.1 GERMANY 92
8.3.1.1 The majority of the costs related to treatments in Germany are covered by the GKV system, thus driving market growth 92
TABLE 111 GERMANY: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 93
TABLE 112 GERMANY: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 93
8.3.2 UK 93
8.3.2.1 The increasing burden of lung cancer in the UK to drive market growth 93
TABLE 113 UK: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 94
TABLE 114 UK: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 94
8.3.3 FRANCE 94
8.3.3.1 Favorable reimbursement support in France to drive the adoption rate for advanced treatments & surgeries 94
TABLE 115 FRANCE: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 95
TABLE 116 FRANCE: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 95
8.3.4 ITALY 95
8.3.4.1 The growing geriatric population in Italy drives the demand for associated treatments 95
TABLE 117 ITALY: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 96
TABLE 118 ITALY: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 96
8.3.5 SPAIN 96
8.3.5.1 Rising life expectancy to drive the geriatric population, thus positively impacting overall market growth in Spain 96
TABLE 119 SPAIN: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 97
TABLE 120 SPAIN: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 97
8.3.6 REST OF EUROPE (ROE) 97
TABLE 121 LUNG CANCER INCIDENCE IN KEY ROE COUNTRIES, 2018 VS. 2025 97
TABLE 122 ROE: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 98
TABLE 123 ROE: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 98
8.4 ASIA 98
FIGURE 16 ASIA: LUNG CANCER SURGERY MARKET SNAPSHOT 99
TABLE 124 ASIA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 99
TABLE 125 ASIA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 100
TABLE 126 ASIA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY,
2016–2019 (NO. OF PROCEDURES) 100
TABLE 127 ASIA: LUNG CANCER SURGICAL DEVICES MARKET, BY COUNTRY,
2020–2026 (NO. OF PROCEDURES) 100
TABLE 128 ASIA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 101
TABLE 129 ASIA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 101
TABLE 130 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 101
TABLE 131 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 101
TABLE 132 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 102
TABLE 133 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 102
TABLE 134 ASIA: THORACOTOMY MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 102
TABLE 135 ASIA: THORACOTOMY MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 102
8.4.1 CHINA 103
8.4.1.1 Rising geriatric population and healthcare spending to drive the market growth in China 103
TABLE 136 CHINA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 103
TABLE 137 CHINA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 103
TABLE 138 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 104
TABLE 139 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 104
TABLE 140 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 104
TABLE 141 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 104
TABLE 142 CHINA: THORACOTOMY MARKET, BY TYPE, 2016–2019
(NO. OF PROCEDURES) 105
TABLE 143 CHINA: THORACOTOMY MARKET, BY TYPE, 2020–2026
(NO. OF PROCEDURES) 105

8.4.2 JAPAN 105
8.4.2.1 Government initiatives for cancer control to drive the market growth in Japan 105
TABLE 144 JAPAN: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 106
TABLE 145 JAPAN: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 106
TABLE 146 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (USD MILLION) 106
TABLE 147 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (USD MILLION) 106
TABLE 148 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 107
TABLE 149 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 107
TABLE 150 JAPAN: THORACOTOMY MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 107
TABLE 151 JAPAN: THORACOTOMY MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 107
8.4.3 INDIA 108
8.4.3.1 The rising population and the growing prevalence of lung cancer due to smoking drives the market growth in India 108
TABLE 152 INDIA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 108
TABLE 153 INDIA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 108
TABLE 154 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (USD MILLION) 109
TABLE 155 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (USD MILLION) 109
TABLE 156 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 109
TABLE 157 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 109
TABLE 158 INDIA: THORACOTOMY MARKET, BY TYPE, 2016–2019
(NO. OF PROCEDURES) 110
TABLE 159 INDIA: THORACOTOMY MARKET, BY TYPE, 2020–2026
(NO. OF PROCEDURES) 110
8.4.4 REST OF ASIA 110
TABLE 160 INCIDENCE OF CANCER IN ASIAN COUNTRIES 110
TABLE 161 ROA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 111
TABLE 162 ROA: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 111
TABLE 163 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016–2019 (USD MILLION) 111
TABLE 164 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2026 (USD MILLION) 112
TABLE 165 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 112
TABLE 166 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 112
TABLE 167 ROA: THORACOTOMY MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 112
TABLE 168 ROA: THORACOTOMY MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 113
8.5 REST OF THE WORLD 113
TABLE 169 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025 113
TABLE 170 ROW: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2016–2019 (USD MILLION) 114
TABLE 171 ROW: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE,
2020–2026 (USD MILLION) 114
TABLE 172 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (USD MILLION) 114
TABLE 173 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (USD MILLION) 114
TABLE 174 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2016–2019 (NO. OF PROCEDURES) 115
TABLE 175 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE,
2020–2026 (NO. OF PROCEDURES) 115
TABLE 176 ROW: THORACOTOMY MARKET, BY TYPE, 2016–2019 (NO. OF PROCEDURES) 115
TABLE 177 ROW: THORACOTOMY MARKET, BY TYPE, 2020–2026 (NO. OF PROCEDURES) 115
9 COMPETITIVE LANDSCAPE 116
9.1 OVERVIEW 116
FIGURE 17 KEY DEVELOPMENTS IN THE LUNG CANCER SURGERY MARKET
(2018 TO 2021) 116
9.2 MARKET SHARE ANALYSIS, 2020 117
FIGURE 18 LUNG CANCER SURGERY DEVICES MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2020 117
9.3 KEY STRATEGIES 118
9.3.1 PARTNERSHIPS AND COLLABORATIONS 118
TABLE 178 PARTNERSHIPS AND COLLABORATIONS, 2018–2021 118
9.3.2 PRODUCT LAUNCHES & REGULATORY APPROVALS 118
TABLE 179 PRODUCT LAUNCHES AND REGULATORY APPROVALS, 2018–2021 118
9.3.3 EXPANSIONS 119
TABLE 180 EXPANSIONS, 2018–2021 119
9.3.4 ACQUISITIONS 120
TABLE 181 ACQUISITIONS, 2018–2021 120
9.3.5 OTHER DEVELOPMENTS 120
TABLE 182 OTHER DEVELOPMENTS, 2018–2021 120

9.4 COMPANY EVALUATION QUADRANT 121
9.4.1 STARS 121
9.4.2 EMERGING LEADERS 121
9.4.3 PERVASIVE PLAYERS 121
9.4.4 PARTICIPANTS 121
FIGURE 19 LUNG CANCER SURGERY MARKET:
COMPETITIVE LEADERSHIP MAPPING (2020) 122
10 COMPANY PROFILES 123
(Business Overview, Products, Key Insights, Recent Developments, MnM View)*
10.1 ETHICON LLC. (A PART OF JOHNSON & JOHNSON GROUP) 123
FIGURE 20 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020) 123
10.2 MEDTRONIC PLC. 126
FIGURE 21 MEDTRONIC PLC.: COMPANY SNAPSHOT (2020) 126
10.3 OLYMPUS CORPORATION 128
FIGURE 22 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 128
10.4 INTUITIVE SURGICAL INC. 131
FIGURE 23 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2020) 131
10.5 SIEMENS HEALTHINEERS 134
FIGURE 24 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 134
10.6 TELEFLEX INCORPORATED 136
FIGURE 25 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020) 136
10.7 ACCURAY INCORPORATED 138
FIGURE 26 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2020) 138
10.8 ANGIODYNAMICS INC. 140
FIGURE 27 ANGIODYNAMICS INC.: COMPANY SNAPSHOT (2020) 140
10.9 KEY SURGICAL LLC. 142
10.10 KLS MARTIN GROUP 143
10.11 ACKERMANN INSTRUMENTE GMBH 145
10.12 KARL STORZ GMBH 146
10.13 SCANLAN INTERNATIONAL, INC. 147
10.14 TROKAMED GMBH 148
10.15 SURGICAL HOLDINGS 149
10.16 FUSIONKRAFT SURGICAL INSTRUMENTS 150
10.17 RICHARD WOLF GMBH 151
10.18 SONTEC INSTRUMENTS INC. 152
10.19 WEXLER SURGICAL INC. 154
10.20 PHOENIX SURGICAL INSTRUMENTS LTD. (A PART OF STERIS IMS) 156
*Details on Business Overview, Products, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX 157
11.1 DISCUSSION GUIDE 157
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
11.3 AVAILABLE CUSTOMIZATIONS 162
11.4 RELATED REPORTS 162
11.5 AUTHOR DETAILS 163



★調査レポート[世界の肺がん手術市場予測:器具別、処置別、ボリュームデータ別] ( Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data - Global Forecast to 2026 / MD4960) 販売に関する免責事項
[世界の肺がん手術市場予測:器具別、処置別、ボリュームデータ別] ( Lung Cancer Surgery Market by Instrument ((Clamps, Foreceps, Trocars, Retractors, Scissors), Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS), Volume Data - Global Forecast to 2026 / MD4960) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆